KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Return on Assets (2016 - 2025)

Historic Return on Assets for Bristol Myers Squibb (BMY) over the last 16 years, with Q3 2025 value amounting to 0.06%.

  • Bristol Myers Squibb's Return on Assets rose 1400.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 1400.0%. This contributed to the annual value of 0.1% for FY2024, which is 1800.0% down from last year.
  • Bristol Myers Squibb's Return on Assets amounted to 0.06% in Q3 2025, which was up 1400.0% from 0.05% recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Return on Assets peaked at 0.09% during Q3 2023, and registered a low of 0.1% during Q4 2024.
  • Moreover, its 5-year median value for Return on Assets was 0.06% (2022), whereas its average is 0.02%.
  • As far as peak fluctuations go, Bristol Myers Squibb's Return on Assets skyrocketed by 1400bps in 2021, and later crashed by -1800bps in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Return on Assets stood at 0.06% in 2021, then grew by 2bps to 0.07% in 2022, then skyrocketed by 33bps to 0.09% in 2023, then tumbled by -211bps to 0.1% in 2024, then skyrocketed by 166bps to 0.06% in 2025.
  • Its Return on Assets was 0.06% in Q3 2025, compared to 0.05% in Q2 2025 and 0.06% in Q1 2025.